Alembic Pharma receives EIR from USFDA for Panelav facility

15 Jun 2018 Evaluate

Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for the inspection carried out by them at Formulation Facility at Panelav during the period from 12th March, 2018 to 20th March, 2018.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

759.55 -5.30 (-0.69%)
21-Jan-2026 15:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1613.75
Dr. Reddys Lab 1160.10
Cipla 1370.00
Zydus Lifesciences 874.80
Lupin 2144.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×